Novartis AG - TOBRADEX & NATACYN - Ownership and Business Overview

Medical ProductsCompany

Novartis AG - TOBRADEX & NATACYN Ownership

Who owns Novartis AG - TOBRADEX & NATACYN?

Novartis AG - TOBRADEX & NATACYN is owned by Eyevance Pharmaceuticals and Hayfin Capital Management. It was acquired on October 16, 2019.

Novartis AG - TOBRADEX & NATACYN Business Overview

Where is Novartis AG - TOBRADEX & NATACYN headquartered?

Novartis AG - TOBRADEX & NATACYN is headquartered in Basel, Switzerland.

What sector is Novartis AG - TOBRADEX & NATACYN in?

Novartis AG - TOBRADEX & NATACYN is a medical products company.

Medical Products M&A Summary in 2019

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2019. The largest medical products acquisition in 2019 was Acelity - which was acquired by 3M Company for $6.7B.

Join Mergr to view all 204 acquisitions of medical products companies in 2019, including 28 acquisitions by private equity firms, and 176 by strategics.

Novartis AG - TOBRADEX & NATACYN

Basel, 4002
Switzerland,

Novartis AG's TOBRADEX is a fixed-dose topical antibiotic and corticosteroid combination indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Novartis AG's NATACYN is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Novartis AG - TOBRADEX & NATACYN

Medical Products Companies , Switzerland Companies